Home » Authors » Anette Breindl

Articles by Anette Breindl

Cousin Of Singulair, Is Celebrex Useful In Cardiac Hypertrophy?

Dec. 4, 2006

By Anette Breindl

One-kind-makes-all may be stem cell pathway to heart

Dec. 1, 2006

By Anette Breindl

Cancer Drug Has Promise In Kidney Disease, Arthritis

Nov. 30, 2006

By Anette Breindl

Cancer Drug Has Promise In Kidney Disease, Arthritis

Nov. 30, 2006

By Anette Breindl

One-Kind-Makes-All Could Be Path To Development Of Heart

Nov. 28, 2006

By Anette Breindl

One-Kind-Makes-All Could Be Path To Development Of Heart

Nov. 28, 2006

By Anette Breindl

Methods Predict How Proteins, Nucleic Acids Get Into Shape

Nov. 22, 2006

By Anette Breindl

Methods Predict How Proteins, Nucleic Acids Get Into Shape

Nov. 22, 2006

By Anette Breindl

At ACR 2006, New Avenues For Building Better Wolftrap

Nov. 21, 2006

By Anette Breindl

At ACR 2006, New Avenues For Building Better Wolftrap

Nov. 21, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.